These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
443 related articles for article (PubMed ID: 33255326)
1. Novel Small-Molecule Scaffolds as Candidates against the SARS Coronavirus 2 Main Protease: A Fragment-Guided in Silico Approach. Augustin TL; Hajbabaie R; Harper MT; Rahman T Molecules; 2020 Nov; 25(23):. PubMed ID: 33255326 [TBL] [Abstract][Full Text] [Related]
2. Establishing an Analogue Based In Silico Pipeline in the Pursuit of Novel Inhibitory Scaffolds against the SARS Coronavirus 2 Papain-Like Protease. Hajbabaie R; Harper MT; Rahman T Molecules; 2021 Feb; 26(4):. PubMed ID: 33672721 [TBL] [Abstract][Full Text] [Related]
3. In silico Study to Evaluate the Antiviral Activity of Novel Structures against 3C-like Protease of Novel Coronavirus (COVID-19) and SARS-CoV. Chunduru K; Sankhe R; Begum F; Sodum N; Kumar N; Kishore A; Shenoy RR; Rao CM; Saravu K Med Chem; 2021; 17(4):380-395. PubMed ID: 32720605 [TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationship (SAR) and molecular dynamics study of withaferin-A fragment derivatives as potential therapeutic lead against main protease (M Ghosh A; Chakraborty M; Chandra A; Alam MP J Mol Model; 2021 Feb; 27(3):97. PubMed ID: 33641023 [TBL] [Abstract][Full Text] [Related]
5. Interaction of small molecules with the SARS-CoV-2 papain-like protease: In silico studies and in vitro validation of protease activity inhibition using an enzymatic inhibition assay. Pitsillou E; Liang J; Ververis K; Hung A; Karagiannis TC J Mol Graph Model; 2021 May; 104():107851. PubMed ID: 33556646 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and Identification of Novel Potential Molecules Against COVID-19 Main Protease Through Structure-Guided Virtual Screening Approach. El Bakri Y; Anouar EH; Ahmad S; Nassar AA; Taha ML; Mague JT; El Ghayati L; Essassi EM Appl Biochem Biotechnol; 2021 Nov; 193(11):3602-3623. PubMed ID: 34324152 [TBL] [Abstract][Full Text] [Related]
7. In-silico pharmacophoric and molecular docking-based drug discovery against the Main Protease (Mpro) of SARS-CoV-2, a causative agent COVID-19. Haider Z; Subhani MM; Farooq MA; Ishaq M; Khalid M; Akram MN; Khan RSA; Niazi AK Pak J Pharm Sci; 2020 Nov; 33(6):2697-2705. PubMed ID: 33867348 [TBL] [Abstract][Full Text] [Related]
8. An Updated Review on SARS-CoV-2 Main Proteinase (M Sabbah DA; Hajjo R; Bardaweel SK; Zhong HA Curr Top Med Chem; 2021; 21(6):442-460. PubMed ID: 33292134 [TBL] [Abstract][Full Text] [Related]
9. Proposal of novel natural inhibitors of severe acute respiratory syndrome coronavirus 2 main protease: Molecular docking and ab initio fragment molecular orbital calculations. Shaji D; Yamamoto S; Saito R; Suzuki R; Nakamura S; Kurita N Biophys Chem; 2021 Aug; 275():106608. PubMed ID: 33962341 [TBL] [Abstract][Full Text] [Related]
10. In Silico Evaluation of Prospective Anti-COVID-19 Drug Candidates as Potential SARS-CoV-2 Main Protease Inhibitors. Ibrahim MAA; Abdelrahman AHM; Allemailem KS; Almatroudi A; Moustafa MF; Hegazy MF Protein J; 2021 Jun; 40(3):296-309. PubMed ID: 33387249 [TBL] [Abstract][Full Text] [Related]
13. Identification of potential plant-based inhibitor against viral proteases of SARS-CoV-2 through molecular docking, MM-PBSA binding energy calculations and molecular dynamics simulation. Gogoi B; Chowdhury P; Goswami N; Gogoi N; Naiya T; Chetia P; Mahanta S; Chetia D; Tanti B; Borah P; Handique PJ Mol Divers; 2021 Aug; 25(3):1963-1977. PubMed ID: 33856591 [TBL] [Abstract][Full Text] [Related]
14. Sterenin M as a potential inhibitor of SARS-CoV-2 main protease identified from MeFSAT database using molecular docking, molecular dynamics simulation and binding free energy calculation. Prajapati J; Patel R; Goswami D; Saraf M; Rawal RM Comput Biol Med; 2021 Aug; 135():104568. PubMed ID: 34174757 [TBL] [Abstract][Full Text] [Related]
15. Targeting SARS-CoV-2 main protease: structure based virtual screening, in silico ADMET studies and molecular dynamics simulation for identification of potential inhibitors. Uniyal A; Mahapatra MK; Tiwari V; Sandhir R; Kumar R J Biomol Struct Dyn; 2022 May; 40(8):3609-3625. PubMed ID: 33226303 [TBL] [Abstract][Full Text] [Related]
16. Repurposing simeprevir, calpain inhibitor IV and a cathepsin F inhibitor against SARS-CoV-2 and insights into their interactions with M J A; Francis D; C S S; K G A; C S; Variyar EJ J Biomol Struct Dyn; 2022 Jan; 40(1):325-336. PubMed ID: 32873185 [TBL] [Abstract][Full Text] [Related]
17. On the search for COVID-19 therapeutics: identification of potential SARS-CoV-2 main protease inhibitors by virtual screening, pharmacophore modeling and molecular dynamics. Hassan A; Arafa RK J Biomol Struct Dyn; 2022 Oct; 40(17):7815-7828. PubMed ID: 33749545 [TBL] [Abstract][Full Text] [Related]